UnknownNot Applicable

Endoscopy and Radiology-guided Ablation for Inoperable Cholangiocarcinoma

Romania30 participantsStarted 2022-08-01

Plain-language summary

This prospective clinical trial aims to assess the feasibility, efficacy, and safety of a personalized radiofrequency ablation protocol coupled with complete biliary drainage for patients presenting with inoperable perihilar cholangiocarcinoma.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * perihilar cholangiocarcinoma * locally advanced disease (unresectable) * M1 (limted to 1 site) Exclusion Criteria: * refusal to sogn the ICF * poor performance status (ECOG \>2) * surgically altered anatomy (i.e Bilroth II or Roux-en-Y interventions) * significant comorbidities * ASA score \>3 * life expectancy \<3 months

What they're measuring

Technical success of ERCP procedure

Timeframe: 2 months

Tumor response

Timeframe: 6 months

Trial details

NCT IDNCT05563870

SponsorClinical Hospital Colentina

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-31

View on ClinicalTrials.gov More Perihilar Cholangiocarcinoma trials